The QR-max index, a novel electrocardiographic index for the determination of left ventricular conduction delay and selection of cardiac resynchronization in patients with non-left bundle branch block.

Cardiac resynchronization therapy Heart failure Left ventricular electrical delay Non-left bundle branch block Non-specific conduction delay Right bundle branch block

Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 10 07 2019
accepted: 19 11 2019
pubmed: 7 12 2019
medline: 19 8 2021
entrez: 7 12 2019
Statut: ppublish

Résumé

Non-left bundle branch block (non-LBBB) remains an uncertain indication for cardiac resynchronization therapy (CRT). Non-LBBB includes right bundle branch block (RBBB) and non-specific LV conduction delay (NSCD), two different electrocardiogram (ECG) patterns which are not generally considered to be associated with LV conduction delay as judged by the invasive assessment of the Q-LV interval. We evaluated whether a novel ECG interval (QR-max index) correlated with the degree of LV conduction delay regardless of the type of non-LBBB ECG pattern, and could, therefore, predict CRT response. In 173 non-LBBB patients on CRT (92 NSCD, 81 RBBB), the QR-max index was measured as the maximum interval from QRS onset to R-wave offset in the limb leads. The correlation between QR-max index and Q-LV interval and the impact of the QR-max index on time to first heart failure hospitalization during 3-year follow-up were assessed. Q-LV correlated better with the QR-max index than with QRSd, particularly in the RBBB group (r = 0.91; p < 0.001 vs. r = 0.19; p < 0.089), while the correlations were r = 0.79 (p < 0.01) and r = 0.68 (p < 0.01), respectively, in the NSCD group. In both groups, the QR-max index was significantly more able than QRSd to identify CRT responders (AUC 0.825 vs. 0.576; p = 0.0008 in RBBB; AUC 0.738 vs. 0.701; p = 0.459 in NSCD). A QR-max index exceeding a cutoff value of 120 ms was associated with CRT response, with predictive values of 86.8 and 81.4% in RBBB and NSCD, respectively. The QR-max index reflects the degree of LV electrical delay regardless of QRS duration in RBBB and NSCD patients and is a useful indicator of suitability for CRT in non-LBBB patients.

Identifiants

pubmed: 31807986
doi: 10.1007/s10840-019-00671-3
pii: 10.1007/s10840-019-00671-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-156

Auteurs

Gianni Pastore (G)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy. gian.past@libero.it.

Massimiliano Maines (M)

Department of Cardiology, Rovereto General Hospital, Rovereto, Italy.

Lina Marcantoni (L)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Daniela Lanza (D)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Francesco Zanon (F)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Franco Noventa (F)

Department of Molecular Medicine, University of Padua, Padova, Italy.

Giorgio Corbucci (G)

Boston Scientific Italy, Milan, Italy.

Gianluca Rigatelli (G)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Enrico Baracca (E)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Marco Zuin (M)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Claudio Picariello (C)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Mauro Carraro (M)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Luca Conte (L)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

Loris Roncon (L)

Department of Cardiology, Rovigo General Hospital, 140, Viale Tre Martiri, 45100, Rovigo, Italy.

S Serge Barold (SS)

Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH